You are here

Retrophin

FDA sets back Travere's plans for kidney disease drug approval

Fierce Biotech

Wed, 05/26/21 - 10:50 am

Travere Therapeutics

clinical trials

Retrophin no more: Shkreli's legacy disappears as former company becomes Travere Therapeutics

Endpoints

Mon, 11/16/20 - 10:29 pm

Travere Therapeutics

Retrophin to buy Orphan Tech for $90M upfront

Seeking Alpha

Thu, 10/22/20 - 11:12 pm

enzyme replacement

Top 7 Companies in Biotech Beach by Revenue

BioSpace

Thu, 12/5/19 - 10:15 am

Acadia Pharmaceuticals

Mirati Therapeutics

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Xconomy

Thu, 08/22/19 - 11:15 am

fosmetpantotenate

Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes

Endpoints

Fri, 08/9/19 - 10:45 am

FDA Approves Retrophin’s New Formula for Cystine Kidney Stones

BioSpace

Mon, 07/1/19 - 07:36 pm

cystine kidney stones

The Week Ahead In Biotech: Pending Clinical Readouts In Focus

Yahoo/Benzinga

Mon, 07/1/19 - 10:32 am

Sangamo Therapeutics

Catalyst Biosciences

Reata Pharmaceuticals

Vertex Pharmaceuticals

Gilead Sciences

TRACON Pharmaceuticals

Sorrento Therapeutics

FDA Action Alert: Regeneron, Sanofi, Celgene

BioSpace

Mon, 06/24/19 - 07:27 pm

Acer Therapeutics

Dova Pharmaceuticals

Nabriva Therapeutics

After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin

Endpoints

Fri, 06/21/19 - 09:53 am

Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues

Endpoints

Mon, 06/3/19 - 11:23 am

Mark Your Calendar For These June PDUFA Dates

Yahoo/Benzinga

Sat, 06/1/19 - 12:52 pm

Amag Pharmaceuticals

Acer Therapeutics

Go or no go? Merck, Regeneron and Alexion await US expansion

EP Vantage

Thu, 05/30/19 - 09:39 am

Dova Pharmaceuticals

Made for TV: Shkreli running his drug company from prison cell, WSJ says

Fierce Pharma

Thu, 03/7/19 - 01:42 pm

Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus

Endpoints

Wed, 03/7/18 - 11:58 am

clinical trials

From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives

Fierce Pharma

Sat, 07/15/17 - 11:33 am

Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin

Endpoints

Fri, 07/7/17 - 10:36 am

Martin Shkreli’s former biotech company Retrophin is leaving Cambridge

Bizjournals.com

Fri, 03/10/17 - 09:39 am

Martin Shkreli in court as securities fraud case moves closer to trial

CNBC

Thu, 01/26/17 - 06:56 pm

securities fraud

4 Key BioPharma Movers in the Past Week

24/7 Wall St

Sun, 09/11/16 - 10:19 pm

Lexicon Pharmaceuticals

Pages